Objective: Cystic thyroid lesions can harbour an occult papillary carcinoma, which fine needle aspiration (FNA) biopsy may fail to detect. Recently, new markers such as galectin-3 lectin have been proposed to distinguish benign from malignant thyroid lesions of follicular origin. The aim of this study was to assess the role of galectin-3 immunodetection in a series of FNA cytological samples of benign and malignant thyroid cystic nodules. Methods: We retrospectively analysed galectin-3 expression by immunoperoxidase staining on 32 cytological paraffin-embedded samples of cystic papillary carcinoma and on 12 samples of benign cysts, both obtained by FNA biopsy. Specificity, sensitivity, positive/negative predictive values, and accuracy of standard cytological examination and galectin-3 immunodetection were assessed. Results: Among cystic papillary carcinomas, 29 of 32 samples were galectin-3 positive, whereas standard FNA cytology made a correct diagnosis in only 25 of 32 samples. All the benign cysts were negative for galectin-3. In comparing the sensitivity and specificity of the two methods, it appeared that both had a 100% specificity, whereas the sensitivity of cytological examination alone was 75% versus 89.3% obtained by galectin-3 immunohistochemistry. Conclusions: Galectin-3 immunostaining represents a valid pre-operative adjunct to pick up malignant cells in those cases where a very poor number of epithelial cells may lead to a cytological misdiagnosis. Therefore, we suggest that in poorly cellular FNA biopsies of simple or complex thyroid cysts, galectin-3 expression by epithelial cells is consistent with a cystic carcinoma and supports surgical treatment indication.
Introduction
In surgical series, cystic thyroid nodules account for 15 to 37% of cases (1), but the true incidence of malignancy in such nodules has never been assessed with certainty, ranging from 0 to 45% in accordance with literature data (2 -9) . The reported discrepancies are partly related to the variable criteria used to define a thyroid cyst. In fact, this term includes simple cysts having an epithelial lining and a thin wall, and cystic nodules resulting from variable degrees of hyperplastic or neoplastic solid nodules cystic degeneration. Cystic nodules encompass papillary carcinoma, which has been reported to undergo cystic changes either in its primary location or in neck lymph node metastases in up to 10% of cases (5, 10 -13) . More rarely, cystic lesions can hide oxyphilic (Hü rthle) cell neoplasms (14) .
The diagnosis of cystic thyroid nodules is usually not a problem when surgical specimens are considered, while it often causes false negative reports in preoperative samples obtained by fine needle aspiration (FNA) biopsies (14, 15) . Since FNA cytology of thyroid nodules is a first choice diagnostic procedure that helps to address the therapeutic strategy (6, 16, 17) , a correct classification of thyroid cysts is of paramount importance. Because of the low number of epithelial cells in the aspirated fluid of most specimens, conventional cytological staining cannot correctly identify all malignant cases. Furthermore, the degenerative changes affecting follicular cells of benign cysts may hamper the recognition of malignant cells, and may constitute an important additional diagnostic pitfall (5) .
Several markers have been proposed to distinguish benign from malignant thyroid lesions. These include high molecular weight cytokeratins that preferentially stain papillary carcinoma cells (18) , thyroperoxidase, which is physiologically expressed by thyrocytes and lost in thyroid carcinoma (19) , E-cadherins and catenins that are down-regulated or disregulated in thyroid cancer (20 -22) , and the fusion protein PAX8-PPARg, which was found to be restricted to thyroid carcinomas (23) . Another promising group of molecules is represented by lectins, i.e. proteins binding specific carbohydrate structures. These include betagalactoside binding protein galectin-3 and CD44-variant 6 (CD44v6). Both these proteins have an altered expression during cell proliferation, malignant transformation and progression, and are involved in cell -cell and cell -matrix interactions. In both surgical and cytological materials, galectin-3 and, to a lower degree, CD44v6 immunocytochemistry have been found to show a high ability in discriminating follicular adenomas from carcinomas of the thyroid (24 -26), galectin-3 expression being restricted to malignant tumours. CD44v6 sensitivity might allow recognition of malignant cells in galectin-3 negative cases (25, 26) , even though its lower specificity requires strictly controlled technical conditions and makes its interpretation rather difficult in some circumstances.
The purpose of this study was to investigate the role of galectin-3 immunodetection in a series of FNA cytological samples of cystic thyroid lesions. We show that galectin-3 is exclusively expressed by malignant epithelial cells of cystic papillary carcinoma, and that its immunohistochemical detection is an additional tool in the pre-operative cytological evaluation of thyroid cysts.
Materials and methods

Cytological specimens
A total of 44 pre-operative specimens obtained by thyroid FNA biopsies performed during a period of 12 years (from 1988 to 2000) were retrospectively collected. These included 28 cytological samples with a histological diagnosis of cystic papillary thyroid carcinoma (CPTC), 4 cases of cervical lymph node cystic metastases of thyroid papillary carcinoma, and 12 additional control cases of haemorrhagic cysts from adenomatous goitres. All the patients suspected for malignancy, for cyst recurrence with repeated inconclusive cytological diagnoses, or for aesthetical or mechanical reasons underwent surgery for an FNA diagnosis. On an ultrasonographic basis, the lesions were classified as completely cystic (liquid) or mixed cystic/solid. In the former group, the lesion was virtually entirely cystic and lined by a thin fibrous wall. Mixed cysts had at least 70% of their volume occupied by fluid and the solid component was restricted to a minor portion of the nodule.
FNA biopsy
FNA biopsies were performed under ultrasonographic guidance (89% of cases) or directly using a 22-gauge (0.7 mm) needle attached to a 30-ml syringe mounted in a syringe-holder. After aspiration, part of the fluid was smeared, fixed, and stained. Two to four Papanicolaou-or Giemsa-stained smears from the aspirated fluid were available for review. The residual amount of fluid was fixed in 70% alcohol, centrifuged and processed for cell block preparation. Finally, paraffin-embedded serial sections from cell blocks were stained with haematoxylin and eosin and with the Papanicolaou stain. The original cytological diagnoses had followed the currently used criteria for FNA cytology of the thyroid (27) , and included 'benign cyst' (5 cases) in the presence of morphologically benign epithelial elements (in at least six groups of ten well preserved follicular cells), 'suspected papillary carcinoma' (25 cases) and 'inconclusive' (14 cases) in the presence of an inadequate FNA specimen.
Immunoperoxidase technique
Immunohistochemistry was performed on 4-mm-thick sections from cell blocks collected onto poly-L-lysinecoated slides, using a standard manual immunoperoxidase procedure with streptavidin peroxidase (LSAB2 kit, Dako, Glostrup, Denmark) and diaminobenzidine as the final reaction product. The presence of epithelial cells in all FNA cases was assessed using an antibody to cytokeratin (clone KL1, diluted 1/50; Immunotech, Marseille, France). Galectin-3 was revealed in FNA cell blocks with a commercial monoclonal antibody (clone 9C4, diluted 1/200; Novocastra, Newcastle, UK) after prior microwave antigen retrieval procedures (three 3-min passages in citrate buffer, pH 6.0). Mounted slides were subsequently examined with a DM-RBE Leica photomicroscope (Leica Microsystems AG, Wetzlar, Germany). In FNA material, the internal positive control for galectin-3 was represented by histiocytes.
Cell block staining evaluation and statistical data
Galectin-3 immunostaining was evaluated by two independent pathologists, who had no knowledge of the previous histological diagnosis, using the following criteria: negative (2 ) case, i.e. no reactivity or some epithelial cells with nuclear reactivity alone, and positive (þ ) case, i.e. epithelial cells with immunostaining in the cytoplasm or in both the cytoplasm and the nucleus.
Sensitivity, specificity, predictive value and diagnostic accuracy were assessed for both standard cytological examination and galectin-3 immunodetection. Histological diagnosis represented the gold-standard. Sensitivity was defined as true positive/(true positive þ false negative), and specificity as true negative/(true negative þ false positive). Positive and negative predictive values were respectively computed as true positive/(true positive þ false positive) and true negative/(true negative þ false negative), whereas diagnostic accuracy was computed as (true positive þ true negative)/(true positive þ false positive þ true negative þ false negative). Finally, the statistical parameters of both methods were compared.
Results
Clinical and immunohistochemical data of each case are summarised in Table 1 .
The female/male ratio was 25/7 (3.6) for papillary carcinomas (including cervical lymph node metastases) and 9/3 (3) for benign cysts. The mean age was 47 and 53 years for benign and malignant lesions respectively. Pathological T stage (pT) of papillary carcinoma diagnoses included pT1 (2 cases), pT2 (24 cases), pT3 (5 cases) and pT4 (1 case).
Upon review, the smears and cell blocks of both the primary and metastatic CPTC cases showed a haemorrhagic or colloid background containing numerous hemosiderin-laden macrophages and variable amounts of epithelial cells in all but two cases (nos 19 and 23). The cells had a morular or papillary arrangement and Figure 1 (a-d) Cervical lymph node cystic metastasis of a thyroid papillary carcinoma (case no. 30). In the cell block of the pre-operative FNA, isolated cells or small papillary aggregates intensely express galectin-3, which is absent in the lymphocyte cluster at the bottom (a). The aspirated nodule was entirely cystic, as it can be seen in the ultrasound image (b) and in the surgical specimen (c).
The asterisk marks the area magnified in (d), containing an oedematous neoplastic papilla lined by irregular cells with nuclear inclusions and grooves. (e-h) Cystic papillary carcinoma of the thyroid (case no. 25). The pre-operative FNA correctly identified papillary aggregates with cells having clear nuclei, grooves and nuclear inclusions, in a haemorrhagic background (e). The cell block contained neoplastic papillae and follicles (f), which were intensely reactive for galectin-3 (g). The corresponding surgical specimen showed a 3-cm cystic tumour (h, top), demarcated by a thick fibrous capsule and containing numerous papillae, macrophages and red blood cells clear nuclei showing the features of papillary carcinoma in 25 cases, including all the cystic cervical metastases (Fig. 1a -d) . Control cases were interpreted as haemorrhagic cysts in the setting of adenomatous goitre on the basis of a haemorrhagic background with macrophages and apparently no epithelial cells. When compared with post-operative histological diagnoses, standard FNA cytology for benign cysts and cervical lymph node cystic metastases reached 100% for both sensitivity and specificity. As far as standard FNA cytology for primary CPTCs is concerned, its specificity was 100%, whereas its sensitivity reached 75% only. This result was caused by 7 false negative cases characterised by the presence of many hemosiderin-laden macrophages in a haemorrhagic background and apparently no epithelial cells in two samples (nos 19 and 23) or epithelial cells lacking features of malignancy in the remaining five. The original standard FNA cytological diagnosis was of an haemorrhagic cyst. Subsequently, these patients underwent thyroidectomy because of the cyst size and/or its rapid re-growth after FNA.
Epithelial cells were searched for in all samples by means of cytokeratin immunostaining. A very poor number of cytokeratin immunoreactive cells was observed in those two CPTCs (nos 19 and 23) that apparently lacked epithelial cells on morphological examination. Nevertheless, all specimens were suitable for galectin-3 immunostaining.
In benign cysts, galectin-3 stained macrophages. No galectin-3 immunoreactivity was detected in epithelial cells or in other elements of the aspirated fluid. In contrast, galectin-3 immunostaining was positive in all the cervical lymph node cystic metastases and in 25/28 (89.3%) cases of primary CPTC (Fig. 1e -h ). As shown in Table 1 , four out of seven false negative cases revealed galectin-3 positive immunostaining, allowing diagnosis of suspected cystic papillary carcinoma in four additional cases that had not been detected by standard cytological evaluation (Fig. 1i -n) . The combination of standard cytological evaluation with galectin-3 immunostaining markedly improved sensitivity, negative predictive value and diagnostic accuracy of the method, as reported in Table 2 .
Discussion
In this study, we show an additional application of galectin-3 immunodetection in the pre-operative FNA cytological assessment of thyroid nodules. In addition to its well established role in separating follicular adenomas from carcinomas (24, 26, 28 -30) , galectin-3 immunohistochemistry proves useful in accurately distinguishing malignant thyroid cysts, namely cystic papillary carcinomas, from benign cysts.
Cystic nodules may constitute up to 20% of all thyroid nodules, but wide variations in the incidence of carcinoma in cysts have been reported in the literature (2 -9). The differential diagnosis may be difficult on standard cyto-morphological grounds, and other pathological features, such as the type of aspirated fluid, do not seem to bear any significance in discriminating benign from malignant cases, as reported by McHenry et al.
(1) and confirmed here. A different condition is the presence of a mixed solid and cystic nodule. Usually, mixed nodules are aspirated again in the solid component after fluid drainage (1) . Nevertheless, the number of epithelial cells may not be sufficient to guarantee a correct interpretation.
Since FNA evaluation of totally or partially cystic nodules represents a relatively common occurrence, the search for accurate differential markers is of paramount importance to avoid false negative diagnoses. Actually, many cases remain indeterminate at standard cytological examination because of a non-diagnostic rather than a false negative FNA result (1). The paucity of epithelial cells may not allow a correct cystic nodule classification, especially in the case of apparently simple cysts lacking a solid component.
We extended the same approach proposed for the diagnosis of follicular neoplasms (24, 26, 29) to cystic nodules of the thyroid, and selected a series of cysts which underwent FNA biopsies and subsequent surgical operation in our hospitals. Cases included 28 primary cystic papillary carcinomas, 4 cervical lymph node cystic metastases of papillary carcinoma, and 12 benign cysts operated on for mechanical reasons as control samples. While the cytological evaluation correctly identified all cystic metastases of papillary carcinoma (true positive), 7 out of 28 primary cystic papillary carcinomas were not recognised at standard cytological examination (false negative; sensitivity 75%). A first matter of concern about these 7 false negative samples was to verify the presence of epithelial cells in the aspirated fluid by means of cytokeratin immunostaining. Since all of them were found to contain rare cytokeratin immunoreactive cells, an additional serial section of each case was then stained for galectin-3 and found to be positive in 4 of 7 specimens, thus raising the method sensitivity to 89.3%. The remaining three samples had a very poor number of epithelial cells, as detected by cytokeratin immunostaining, but no galectin-3 expression. As a matter of fact, the false negative diagnosis was confirmed in these poorly cellular specimens even after galectin-3 immunostaining. We are inclined to consider that a diagnosis of inadequate material would have probably been more appropriate, as also suggested by other authors (1, 5) . In all the other samples galectin-3 confirmed the cytological diagnosis of CPTC and was equally effective in purely cystic as in mixed solid/cystic papillary carcinomas. In the present study we observed a 100% specificity of the method, a finding which needs to be confirmed in a larger series, since in the current study the number of control cases is rather small. In fact, recent literature data (31 -33) showed that normal thyroid cells may occasionally express galectin-3 immunoreactivity. In our experience and that of others (31) , this may, at least in part, be due to an unspecific reaction when biotin-based detection systems are employed. Nevertheless, the possibility of false positive galectin staining cannot be excluded, and the immunocytochemical findings should be analysed in the context of the morphological evaluation, as a valid adjunct to conventional stainings. These findings raise a final question about the practical applications of this immunohistochemical procedure. Should galectin-3 immunostaining be proposed in FNAs of all thyroid cysts, or should a selection of cases be required? In our opinion, FNA biopsies having a well represented epithelial component with clear-cut signs of malignancy (i.e. papillary aggregates and/or nuclear features of papillary carcinoma) should be reported as suspected CPTCs and referred to the surgeon. Galectin-3 may be confirmatory, but is not designed to solve such apparently 'easy' cases. The same holds true for simple cysts containing only macrophages and blood cells, which may be monitored with ultrasonography and possibly repeated FNA biopsy. In contrast, those cases having a limited amount of epithelial aggregates or indeterminate cytological features may benefit from the additional test for galectin-3, to better address the therapeutic or follow-up strategy. In addition, it has to be pointed out that in such cases the recognition of the epithelial origin in sparse, isolated galectin-3 positive cells could be difficult, and could lead to false positivities (i.e. due to immunoreactive macrophages). The detection of cytokeratin and galectin-3 in serial sections could help in these cases to confirm the epithelial nature of galectin-3 positive small clusters. The vast majority of the cystic papillary carcinomas here studied had a diameter larger than 1 cm, it being very difficult to perform FNA on smaller cystic lesions. It is however questionable whether missing the diagnosis in pT1 cases would have been of clinical relevance. Only 2 cases in our series had a pT1 stage on histological examination, one of these being multifocal.
Galectin-3 expression was also demonstrated in the four cases of cervical lymph node cystic metastases of thyroid occult papillary carcinoma. Cervical lymph node metastases are a common presentation of otherwise occult papillary thyroid carcinoma. However, prominent cystic features are relatively uncommon, as demonstrated by only 27 cases reported to date in the literature (11, 12) . Although in such cases the diagnostic approach differs from that reserved for primary thyroid locations, thyroglobulin being the first choice marker, the identification of galectin-3 positive epithelial cells may represent a further indicator of thyroidal neoplastic cyst. In fact, to our knowledge, non-neoplastic epithelia, branchial/epidermal cysts, and other head and neck cystic tumours have never been reported to express galectin-3 (11, 12) .
In conclusion, although galectin-3 is also expressed by macrophages, usually abundant in the aspirated cystic fluid, its presence in epithelial cells of thyroid cysts may address a diagnosis of cystic neoplasm (i.e. papillary carcinoma) and suggests a cautious interpretation of FNA results. A surgical resection is thus advisable in thyroid cystic nodules containing galectin-3 positive epithelial cells.
